Literature DB >> 11247858

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis.

L Laloux1, M C Voisin, J Allain, N Martin, L Kerboull, X Chevalier, P Claudepierre.   

Abstract

OBJECTIVE: To determine which inflammatory cell types are present in entheses from patients with spondyloarthropathy (SpA) compared with patients with rheumatoid arthritis (RA) or osteoarthritis (OA).
METHODS: Enthesis specimens were obtained during orthopaedic procedures in eight patients with SpA, four with RA, and three with OA. After decalcification, the lymphocyte subsets (CD3, CD4, CD8, CD20) in the bone marrow component of each enthesis were measured by an immunohistochemical technique.
RESULTS: Oedema and an inflammatory infiltrate were present in all the SpA specimens, being clearly predominant in the bone marrow component of the entheses. The density of all cell types in the bone marrow was significantly higher in the SpA group than in the two other groups. The cell type CD3+ showed the greatest difference between the SpA and RA groups, being increased fivefold in the SpA group. Within the SpA group, CD3+ cells were considerably more numerous than CD20+ cells-a difference from the RA group-and the predominant T cells were CD8+.
CONCLUSION: Persistent oedema with an inflammatory infiltrate composed predominantly of CD8+ cells was noted in the entheses of patients with SpA, being predominant in the bone marrow. These results suggest that CD8+ cells may have a key role in local inflammation in SpAs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247858      PMCID: PMC1753596          DOI: 10.1136/ard.60.4.316

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis.

Authors:  B L Kidd; K Moore; M T Walters; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

2.  Pathogenesis of square bodies in ankylosing spondylitis.

Authors:  M Aufdermaur
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

3.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

4.  [Anatomo-pathological study of enthesopathies in inflammatory spondylarthropathies].

Authors:  J B Paolaggi; M Durigon; P Pie Pou; P Struz; J M Le Parc
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-03

5.  Enthesopathy of rheumatoid and ankylosing spondylitis.

Authors:  J Ball
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

Review 6.  Seronegative spondylarthropathies.

Authors:  F C Arnett
Journal:  Bull Rheum Dis       Date:  1987

7.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

8.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

Review 9.  Enthesitis in spondyloarthropathy.

Authors:  D McGonagle; M A Khan; H Marzo-Ortega; P O'Connor; W Gibbon; P Emery
Journal:  Curr Opin Rheumatol       Date:  1999-07       Impact factor: 5.006

10.  An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

View more
  37 in total

Review 1.  New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Authors:  J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Advances in the understanding of entheseal inflammation.

Authors:  Dennis McGonagle; Michael Benjamin; Helena Marzo-Ortega; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

3.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 4.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 5.  Clinical observations programme in SpA: disease parameters, treatment options and practical management issues.

Authors:  Dirk Elewaut; Filip Van den Bosch; Gust Verbruggen; Filip de Keyser; Bert Vander Cruyssen; Herman Mielants
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

Review 6.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

7.  Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine.

Authors:  Seung Min Son; Sung Hoon Choi; Jong Ki Shin; Tae Sik Goh; Jung Sub Lee
Journal:  Eur Spine J       Date:  2019-02-11       Impact factor: 3.134

8.  T-cell responses to versican in ankylosing spondylitis.

Authors:  Tae-Jong Kim; Tae-Hwan Kim; Hyun-Joo Lee; Bitnara Lee; A Robin Poole; Robert D Inman
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

9.  A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations.

Authors:  Filip Van den Bosch
Journal:  Clin Rheumatol       Date:  2009-12-03       Impact factor: 2.980

10.  Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.

Authors:  Eric Toussirot; Philippe Saas; Marina Deschamps; Fabienne Pouthier; Lucille Perrot; Sylvain Perruche; Jacqueline Chabod; Pierre Tiberghien; Daniel Wendling
Journal:  Arthritis Res Ther       Date:  2009-07-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.